Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Hackl

Showing results (31-40 of 161) with videos related to

Pageof 17
Sort By:
Gynecologic Oncology|February 9, 2023
An angiogenic tumor phenotype predicts poor prognosis in ovarian cancerVerena Wieser, Irina Tsibulak, Daniel Uwe Reimer, et al.
Clinical Colorectal Cancer|May 8, 2019
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal CancerFlorian Huemer, Verena Schlintl, Stefan Hecht, et al.
Cancers|October 3, 2020
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 TherapyFlorian Huemer, Gudrun Piringer, Verena Schlintl, et al.
Molecular Therapy. Nucleic Acids|June 13, 2025
Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variantGlory Ranches, Hubert Hackl, Viktoria Zaderer, et al.
Annals of Hematology|May 1, 2017
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trialLukas Weiss, Thomas Melchardt, Alexander Egle, et al.
Plos One|November 9, 2013
The human placental sexome differs between trophoblast epithelium and villous vessel endotheliumSilvija Cvitic, Mark S Longtine, Hubert Hackl, et al.
The Journal of Investigative Dermatology|June 20, 2020
Initial Evidence of Distinguishable Bacterial and Fungal Dysbiosis in the Skin of Patients with Atopic Dermatitis or Netherton SyndromeVerena Moosbrugger-Martinz, Hubert Hackl, Robert Gruber, et al.
Cancers|June 12, 2019
Clinical Impact of RANK Signalling in Ovarian CancerVerena Wieser, Susanne Sprung, Irina Tsibulak, et al.
Oncotarget|April 18, 2018
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancerFlorian Huemer, Gabriel Rinnerthaler, Theresa Westphal, et al.
Acta Oncologica (Stockholm, Sweden)|November 4, 2020
Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohortIrina Tsibulak, Verena Wieser, Hannah Welponer, et al.
Pageof 17

Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|February 9, 2023
An angiogenic tumor phenotype predicts poor prognosis in ovarian cancerVerena Wieser, Irina Tsibulak, Daniel Uwe Reimer, et al.
Clinical Colorectal Cancer|May 8, 2019
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal CancerFlorian Huemer, Verena Schlintl, Stefan Hecht, et al.
Cancers|October 3, 2020
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 TherapyFlorian Huemer, Gudrun Piringer, Verena Schlintl, et al.
Molecular Therapy. Nucleic Acids|June 13, 2025
Differentially expressed ncRNAs as key regulators in infection of human bronchial epithelial cells by the SARS-CoV-2 Delta variantGlory Ranches, Hubert Hackl, Viktoria Zaderer, et al.
Annals of Hematology|May 1, 2017
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trialLukas Weiss, Thomas Melchardt, Alexander Egle, et al.
Plos One|November 9, 2013
The human placental sexome differs between trophoblast epithelium and villous vessel endotheliumSilvija Cvitic, Mark S Longtine, Hubert Hackl, et al.
The Journal of Investigative Dermatology|June 20, 2020
Initial Evidence of Distinguishable Bacterial and Fungal Dysbiosis in the Skin of Patients with Atopic Dermatitis or Netherton SyndromeVerena Moosbrugger-Martinz, Hubert Hackl, Robert Gruber, et al.
Cancers|June 12, 2019
Clinical Impact of RANK Signalling in Ovarian CancerVerena Wieser, Susanne Sprung, Irina Tsibulak, et al.
Oncotarget|April 18, 2018
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancerFlorian Huemer, Gabriel Rinnerthaler, Theresa Westphal, et al.
Acta Oncologica (Stockholm, Sweden)|November 4, 2020
Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohortIrina Tsibulak, Verena Wieser, Hannah Welponer, et al.
Pageof 17